TrialBritish journal of clinical pharmacology2002

Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide).

Charlotte van Kesteren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.